Analyst Viewpoint
Increase in prevalence of chronic diseases and growth in biopharmaceutical and biotechnology industries are propelling the immunoassay market progress. Immunoassays are gaining popularity in the treatment of cancer, diabetes, and other chronic diseases. Growth in geriatric population is also boosting demand for immunoassays.
Rise in concerns regarding food contamination and lack of hygiene is likely to offer lucrative immunoassay market opportunities to key players. Leading players in the industry are investing in innovative drug development techniques to expand their product portfolio. They are also developing compact and innovative analyzers for mid to high-workflow laboratories.
Immunoassays or immunologic assays detect the presence of a specific molecule in a sample using antibody-antigen binding reactions. Immunoassays play a crucial role in several bioanalytical methodologies such as food monitoring, biopharmaceutical analysis, environmental monitoring and security, immune system tests, and clinical diagnostics. Immunoassays are developed to provide quantitative, semiquantitative, or qualitative detection of analytes.
Immunoassay testing works by utilizing antibodies to detect small biological substances in the blood and other bodily fluids. One of the popular methods of antibody testing is lateral flow immunoassay. Lateral flow immunoassay is a membrane-based technique to detect specific analytes in complex samples. High sensitivity and specificity, simple and user-friendly operation, and low sample volume requirement are major advantages of lateral flow immunoassay.
Changes in eating habits, sedentary lifestyles, and physical inactivity are leading to a surge in the prevalence of chronic diseases among the population. Immunoassay techniques are used to diagnose various chronic diseases including cardiovascular diseases, cancer, diabetes, nephrological diseases, mellitus, autoimmune diseases, and infections.
Growth in prevalence of cancer is propelling the immunoassay industry growth. According to the World Health Organization, cancer is a leading cause of fatalities globally and accounted for around 10 million deaths in 2020. The most common types of cancer diagnosed are lung, rectum and prostate, and breast cancers.
Cancer diagnosis is done using immunoassay techniques by analyzing genes, proteins, and other substances called tumor markers or biomarkers. Immunoassay techniques for cancer biomarkers are adopted to ensure early detection and accuracy of diagnosis. Thus, rise in demand for immunoassays in cancer diagnosis is driving the market dynamics.
Immunoassay are utilized in gene and cell therapy and vaccine development. Immunoassays provide a powerful and versatile analytical toolset in biopharmaceutical analysis, allowing manufacturers and researchers to assess the potency, safety, and quality of biopharmaceutical drugs. Public healthcare organizations and governments in various countries are investing in drug development, which is bolstering the immunoassay market size.
Immunoassays are extensively used for food toxins such as mycotoxins, pesticide residues, identification of bacteria and viruses, process-induced toxins and drugs, and detection of allergens in food. Food testing activities are increasing in the food & beverage sector due to the implementation of stringent government regulations on food safety. Hence, increase in awareness about maintaining food hygiene is boosting the market development.
As per the latest market insights, North America accounted for the largest market share in 2022. Increase in prevalence of infectious and chronic diseases and growth in geriatric population are augmenting the market expansion. Moreover, rapid development in healthcare infrastructure and surge in investment in drug development technologies are likely to bolster the immunoassay market share in the next few years.
According to the Pharmaceutical Research and Manufacturers of America, companies in the biopharmaceutical industry invested around US$ 102.3 Bn in research for drug development in 2021. As per the latest immunoassay market forecast, increase in research and development of advanced therapies for the treatment of chronic and cardiovascular diseases is projected to fuel the market value in the near future.
Leading companies are following innovative immunoassay market trends to launch new diagnostic products. They are forming strategic partnerships and mergers to enhance their production capacities and broaden their presence in global markets. Key players are adopting advanced methodologies for the diagnosis and treatment of infectious diseases to improve business performance. They are also offering immunoassay techniques for cancer biomarkers.
Some of the players in the industry are F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers (Siemens AG), DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA.
These companies are profiled in the immunoassay industry report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 31.5 Bn |
| Market Forecast (Value) in 2031 | US$ 48.7 Bn |
| Growth Rate (CAGR) | 5.0% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 31.5 Bn in 2022
It is projected to register a CAGR of 5.0% from 2023 to 2031
Increase in prevalence of chronic diseases and growth in biopharmaceutical and biotechnology industries
North America was the most lucrative region in 2022
F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers (Siemens AG), DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Immunoassay Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Immunoassay Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Immunoassay Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Analyzers
6.3.2. Consumables
6.4. Market Attractiveness, by Product
7. Global Immunoassay Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. Chemiluminescence Immunoassay (CLIA)
7.3.2. Enzyme-linked Immunoassay (ELISA)
7.3.3. Enzyme-linked Immunofluorescent Assay (ELFA)
7.3.4. Radioimmunoassay (RIA)
7.3.5. Others
7.3.6. 7.4 Market Attractiveness, by Technology
8. Global Immunoassay Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Infectious Disease
8.3.2. Endocrinology
8.3.3. Oncology
8.3.4. Cardiology
8.3.5. Orthopedics
8.3.6. Others
8.4. Market Attractiveness, by Application
9. Global Immunoassay Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Diagnostic Laboratories
9.3.2. Blood Banks
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Immunoassay Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Immunoassay Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Analyzers
11.2.2. Consumables
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. Chemiluminescence Immunoassay (CLIA)
11.4.2. Enzyme-linked Immunoassay (ELISA)
11.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
11.4.4. Radioimmunoassay (RIA)
11.4.5. Others
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by Application, 2017–2031
11.6.1. Infectious Disease
11.6.2. Endocrinology
11.6.3. Oncology
11.6.4. Cardiology
11.6.5. Orthopedics
11.6.6. Others
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals & Diagnostic Laboratories
11.8.2. Blood Banks
11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product
11.11.2. By Technology
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Immunoassay Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Analyzers
12.2.2. Consumables
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Chemiluminescence Immunoassay (CLIA)
12.4.2. Enzyme-linked Immunoassay (ELISA)
12.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
12.4.4. Radioimmunoassay (RIA)
12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Infectious Disease
12.6.2. Endocrinology
12.6.3. Oncology
12.6.4. Cardiology
12.6.5. Orthopedics
12.6.6. Others
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals & Diagnostic Laboratories
12.8.2. Blood Banks
12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product
12.11.2. By Technology
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Immunoassay Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Analyzers
13.2.2. Consumables
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Chemiluminescence Immunoassay (CLIA)
13.4.2. Enzyme-linked Immunoassay (ELISA)
13.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
13.4.4. Radioimmunoassay (RIA)
13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Infectious Disease
13.6.2. Endocrinology
13.6.3. Oncology
13.6.4. Cardiology
13.6.5. Orthopedics
13.6.6. Others
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals & Diagnostic Laboratories
13.8.2. Blood Banks
13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product
13.11.2. By Technology
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Immunoassay Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Analyzers
14.2.2. Consumables
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Chemiluminescence Immunoassay (CLIA)
14.4.2. Enzyme-linked Immunoassay (ELISA)
14.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
14.4.4. Radioimmunoassay (RIA)
14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Infectious Disease
14.6.2. Endocrinology
14.6.3. Oncology
14.6.4. Cardiology
14.6.5. Orthopedics
14.6.6. Others
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals & Diagnostic Laboratories
14.8.2. Blood Banks
14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product
14.11.2. By Technology
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Immunoassay Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Analyzers
15.2.2. Consumables
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Technology, 2017–2031
15.4.1. Chemiluminescence Immunoassay (CLIA)
15.4.2. Enzyme-linked Immunoassay (ELISA)
15.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
15.4.4. Radioimmunoassay (RIA)
15.4.5. Others
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Infectious Disease
15.6.2. Endocrinology
15.6.3. Oncology
15.6.4. Cardiology
15.6.5. Orthopedics
15.6.6. Others
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals & Diagnostic Laboratories
15.8.2. Blood Banks
15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product
15.11.2. By Technology
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Danaher Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Abbott Laboratories
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Siemens Healthineers (Siemens AG)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. DiaSorin S.p.A.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Sysmex Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. bioMerieux SA
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Ortho Clinical Diagnostics
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Thermo Fisher Scientific, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Becton, Dickinson and Company
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Merck kGaA
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Immunoassay Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 08: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 13: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 14: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 19: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 24: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 28: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 29: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Immunoassay Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Immunoassay Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Immunoassay Market Value Share, by Product, 2022
Figure 04: Global Immunoassay Market Revenue (US$ Mn), by Technology, 2022
Figure 05: Global Immunoassay Market Value Share, by Technology, 2022
Figure 06: Global Immunoassay Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Immunoassay Market Value Share, by Application, 2022
Figure 08: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Immunoassay Market Value Share, by End-user, 2022
Figure 10: Global Immunoassay Market Value Share, by Region, 2022
Figure 11: Global Immunoassay Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 13: Global Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 14: Global Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 15: Global Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 16: Global Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 17: Global Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 18: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Immunoassay Market Value Share, by End-user, 2022
Figure 20: Global Immunoassay Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Immunoassay Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Immunoassay Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Immunoassay Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 26: North America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 27: North America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 28: North America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Immunoassay Market Attractiveness Analysis, by Product, 2023–2031
Figure 30: North America Immunoassay Market Attractiveness Analysis, by Technology, 2023–2031
Figure 31: North America Immunoassay Market Attractiveness Analysis, by Application, 2023–2031
Figure 32: North America Immunoassay Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 37: Europe Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 38: Europe Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 39: Europe Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Immunoassay Market Attractiveness Analysis, by Product, 2023–2031
Figure 41: Europe Immunoassay Market Attractiveness Analysis, by Technology, 2023–2031
Figure 42: Europe Immunoassay Market Attractiveness Analysis, by Application, 2023–2031
Figure 43: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2023–2031
Figure 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 48: Asia Pacific Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 49: Asia Pacific Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Immunoassay Market Attractiveness Analysis, by Product, 2023–2031
Figure 52: Asia Pacific Immunoassay Market Attractiveness Analysis, by Technology, 2023–2031
Figure 53: Asia Pacific Immunoassay Market Attractiveness Analysis, by Application, 2023–2031
Figure 54: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Latin America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 59: Latin America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 60: Latin America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 61: Latin America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Immunoassay Market Attractiveness Analysis, by Product, 2023–2031
Figure 63: Latin America Immunoassay Market Attractiveness Analysis, by Technology, 2023–2031
Figure 64: Latin America Immunoassay Market Attractiveness Analysis, by Application, 2023–2031
Figure 65: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2023–2031
Figure 66: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 70: Middle East & Africa Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 71: Middle East & Africa Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 72: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Product, 2023–2031
Figure 74: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Technology, 2023–2031
Figure 75: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Application, 2023–2031
Figure 76: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Immunoassay Market
*86 figures and 60 tables includes